GlassScriptPhysician profile
Julie A Maughan
NPI 1114098357
$1,608.86
in general payments reported to CMS, 2019-2025
21 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $54.85 · 2021: $150 · 2022: $376 · 2023: $204 · 2024: $328 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Education: $85.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.31 |
| Education | $85.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $294.69 | 2022-2025 | |
| Allergan, INC. | $256.37 | 2020-2022 | |
| Galderma Laboratories, L.P. | $164.04 | 2019-2024 | Aklief |
| Janssen Biotech, INC. | $148.68 | 2022-2024 | Tremfya |
| Amgen INC. | $103.91 | 2019-2022 | |
| Leo Pharma INC. | $72.95 | 2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $64.60 | 2019-2025 | |
| Dermavant Sciences, INC. | $60.60 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $59.70 | 2022-2025 | Libtayo, Dupixent |
| Organon LLC | $53.60 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $51.19 | 2021 | |
| Novartis Pharmaceuticals Corporation | $47.50 | 2019-2024 | |
| Biofrontera INC. | $44.60 | 2019-2020 | |
| Lilly USA, LLC | $38.74 | 2019-2024 | Taltz |
| Arcutis Biotherapeutics, INC. | $34.78 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.93 | 2019-2022 | |
| Genentech USA, INC. | $18.66 | 2019 | |
| Botanix Sb INC | $18.00 | 2025 | Sofdra |
| Dermira, INC. | $17.21 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.35 | 2019 | |
| Dusa Pharmaceuticals, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Maughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.